Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Cash from Investing Activities (2025)

Updated

Drugs Made In America Acquisition's Cash from Investing Activities was -$231.15 million in FY2025.

Analysis

Drugs Made In America Acquisition (DMAA) Cash from Investing Activities (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 BlackRock 165.40 Bn 111.76 Bn - -460.00 Mn
2 Spdr Gold Trust 133.61 Bn -424.39 Bn - -
3 Blackstone 84.03 Bn 78.95 Bn - -31.96 Mn
4 Brookfield 82.79 Bn -82.59 Bn 4.47 Bn -
5 Kkr 80.75 Bn 47.23 Bn - 634.87 Mn
6 Brookfield Asset Management 71.44 Bn 67.69 Bn - -308.00 Mn
7 Apollo Global Management 66.43 Bn 4.11 Bn 10.56 Bn -15.54 Bn
8 Wheaton Precious Metals 61.87 Bn 57.29 Bn 687.86 Mn -10.27 Mn
9 Franco Nevada 46.42 Bn 43.78 Bn 451.00 Mn -101.40 Mn
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -231.15 Mn
API Access

Drugs Made In America Acquisition Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=DMAA&period=max&api_key=YOUR_API_KEY